NRXP NRX Pharmaceuticals, Inc.
$2.69▲ +5.49%
Healthcare
Other
After hours
$2.73▲ +1.49%
Oct 27, 5:32 PM ET
Volume 736.2K
Avg Volume (10D) 908.8K
Key Metrics & Fundamentals
Market Cap
$116.47M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.62 - 5.06
% vs 50 MA
-13.59%
% vs 200 MA
-9.20%
RSI-14
43.9
MACD Histogram
+0.0100
Beta (1Y vs SPY)
2.11
Free Cash Flow
-$9.77M
Gross Rev
$1.10M
Gross Profit
$426,000
EBITDA
-$6.32M
COGS
$675,000
Operating Exp
$6.93M
Operating Income
-$6.50M
EBIT
-$6.50M
Pretax Income
-$16.52M
Net Income
-$16.52M
EPS (Diluted)
-0.44
Price & Volume History
Loading chart…
Recent News
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Oct 19, 2026 9:22 AM ET
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine
GlobeNewswire · Oct 19, 2026 8:30 AM ET
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
GlobeNewswire · Oct 15, 2026 8:27 AM ET
NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression
GlobeNewswire · Sep 30, 2026 7:00 AM ET
Ono Pharmaceutical Co. (OPHLF) Soars 13.9%: Is Further Upside Left in the Stock?
Zacks · Sep 24, 2026 7:00 AM ET
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
GlobeNewswire · Sep 15, 2026 3:11 PM ET
GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)
GlobeNewswire · Sep 14, 2026 7:00 AM ET
NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System
MT Newswires · Sep 11, 2026 7:32 AM ET
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
GlobeNewswire · Sep 11, 2026 7:00 AM ET
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 8, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NRXP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.